XERIS BIOPHARMA HOLDINGS, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2023-11-09: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2023-11-09: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2023-08-08: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2023-08-08: Form 10-Q; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2023-11-09 | 10-Q | Smaller reporting company | Yes |
| 2023-11-09 | 10-Q | Emerging growth company | Yes |
| 2023-08-08 | 10-Q | Smaller reporting company | Yes |
| 2023-08-08 | 10-Q | Emerging growth company | Yes |
| 2023-05-09 | 10-Q | Smaller reporting company | Yes |
| 2023-05-09 | 10-Q | Emerging growth company | Yes |
| 2023-03-08 | 10-K | Smaller reporting company | Yes |
| 2023-03-08 | 10-K | Emerging growth company | Yes |
| 2022-11-09 | 10-Q | Smaller reporting company | Yes |
| 2022-11-09 | 10-Q | Emerging growth company | Yes |
| 2022-08-10 | 10-Q | Smaller reporting company | Yes |
| 2022-08-10 | 10-Q | Emerging growth company | Yes |
| 2022-05-11 | 10-Q | Smaller reporting company | Yes |
| 2022-05-11 | 10-Q | Emerging growth company | Yes |
| 2022-03-11 | 10-K | Smaller reporting company | Yes |
| 2022-03-11 | 10-K | Emerging growth company | Yes |
| 2021-11-10 | 10-Q | Stock registered under Section 12(b) | Common Stock, par value $0.0001 per share · XERS · The Nasdaq Global Select Market |
| 2021-11-10 | 10-Q | Smaller reporting company | Yes |
| 2021-11-10 | 10-Q | Emerging growth company | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |